{
    "clinical_study": {
        "@rank": "163020", 
        "arm_group": [
            {
                "arm_group_label": "Levamisole+cyclosporin A+Glucocorticoids", 
                "arm_group_type": "Experimental", 
                "description": "Levamisole+cyclosporin A+Glucocorticoids"
            }, 
            {
                "arm_group_label": "cyclosporin A+Glucocorticoids", 
                "arm_group_type": "Active Comparator", 
                "description": "cyclosporin A+Glucocorticoids"
            }, 
            {
                "arm_group_label": "Glucocorticoids", 
                "arm_group_type": "Active Comparator", 
                "description": "Glucocorticoids"
            }
        ], 
        "brief_summary": {
            "textblock": "Paroxysmal nocturnal hemoglobinuria is an acquired chronic hemolytic anemia,this study is\n      designed to evaluate the safety and efficacy of Levamisole combined with cyclosporine A in\n      patients with Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the setting of\n      another bone marrow  failure syndromes"
        }, 
        "brief_title": "Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)", 
        "completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Paroxysmal Nocturnal Hemoglobinuria", 
            "Hemoglobinuria", 
            "Hemoglobinuria, Paroxysmal", 
            "Proteinuria", 
            "Urination Disorders", 
            "Thrombosis", 
            "Bone Marrow Failure", 
            "Aplastic Anemia,", 
            "Anemia, Hemolytic"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Anemia, Aplastic", 
                "Anemia, Hemolytic", 
                "Hemoglobinuria", 
                "Hemoglobinuria, Paroxysmal", 
                "Pancytopenia", 
                "Proteinuria", 
                "Thrombosis", 
                "Urination Disorders", 
                "Hemolysis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder of the\n      hematopoietic stem cell characterized by intravascular hemolysis, hemoglobinuria, anemia,\n      and thrombosis, Patients may be at high risk of thrombosis and may develop bone marrow\n      failure or aplastic anemia, with low white blood cell and platelet counts,because the\n      manifestation and pathologic processes are complicate,the treatment is very difficult,this\n      study is designed to evaluate the safety and efficacy of Levamisole combined with\n      cyclosporine A in patients with Subclinical Paroxysmal Nocturnal Hemoglobinuria and  PNH in\n      the setting of another bone marrow  failure syndromes"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Clinical and biochemical signs of Subclinical Paroxysmal Nocturnal Hemoglobinuria and\n             PNH in the setting of another bone marrow  failure syndromes\n\n          2. Diagnosis confirmed by Ham's test or Flow cytometry Patients have any Flow cytometry\n             data\n\n          3. patient should complete levamisole study for at least half a year\n\n        Exclusion Criteria:\n\n          1. Active infection which requires antibiotic treatment\n\n          2. Pregnant or lactating women\n\n          3. Epilepsy and mental illness\n\n          4. Kidney and liver function abnormal"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01760096", 
            "org_study_id": "PNH-2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Levamisole+cyclosporin A+Glucocorticoids", 
                "description": "Levamisole 2.5mg/kg every other day cyclosporin A 3-5mg/kg every other day Glucocorticoids0.25 mg/kg every day(prednisone)", 
                "intervention_name": "Levamisole+cyclosporin A+Glucocorticoids", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Levamisole", 
                    "cyclosporin A", 
                    "Glucocorticoids"
                ]
            }, 
            {
                "arm_group_label": "cyclosporin A+Glucocorticoids", 
                "description": "cyclosporin A 3-5mg/kg every day Glucocorticoids0.25mg/kg every day(prednisone)", 
                "intervention_name": "cyclosporin A+Glucocorticoids", 
                "intervention_type": "Drug", 
                "other_name": [
                    "cyclosporin A", 
                    "Glucocorticoids"
                ]
            }, 
            {
                "arm_group_label": "Glucocorticoids", 
                "description": "Glucocorticoids0.25mg/kg every day(prednisone)", 
                "intervention_name": "Glucocorticoids", 
                "intervention_type": "Drug", 
                "other_name": "Glucocorticoids"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclosporins", 
                "Cyclosporine", 
                "Levamisole", 
                "Glucocorticoids", 
                "Physiological Effects of Drugs"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Paroxysmal Nocturnal Hemoglobinuria", 
            "Anemia", 
            "Hematologic Diseases", 
            "bone marrow failure", 
            "Immunologic Factors", 
            "Physiological Effects of Drugs", 
            "Levamisole", 
            "cyclosporine A"
        ], 
        "lastchanged_date": "January 1, 2013", 
        "link": {
            "description": "CBD", 
            "url": "http://www.chinablood.com.cn"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Tianjin", 
                    "country": "China", 
                    "state": "Tianjin", 
                    "zip": "300020"
                }, 
                "name": "Institute of Hematology & Blood Diseases Hospital,"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "Phase II Study of the Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)", 
        "overall_official": {
            "affiliation": "Institute of Hematology & Blood Diseases Hospital", 
            "last_name": "yizhou zheng, doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "she got blood transfusion-independent,the hemoglobin became higher", 
            "measure": "Number of patients in each group in complete or partial remission", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "reference": {
            "PMID": "16051736", 
            "citation": "Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Soci\u00e9 G; International PNH Interest Group. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005 Dec 1;106(12):3699-709. Epub 2005 Jul 28. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01760096"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Institute of Hematology & Blood Diseases Hospital", 
            "investigator_full_name": "Yizhou Zheng", 
            "investigator_title": "Vice director of the therapeutic centre of anemic diseases", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Institute of Hematology & Blood Diseases Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institute of Hematology & Blood Diseases Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}